The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB, -0.31% and Eisai Co. Ltd. ESALF, +1.20% Alzheimer’s treatment...
This article is reprinted by permission from NerdWallet. The investing information provided on this page is for educational purposes only. NerdWallet does not offer advisory...
AbbVie Inc. (NYSE:ABBV) is one of those businesses where I expressed slightly different opinions in different articles over the years and while this might...
Chip stocks underperformed the broader market Thursday after the semiconductor industry logged its 11th month in a row of steep losses from the year-ago...